{
  "retracted": false,
  "timestamp": 1403740800000,
  "updates": [
    {
      "timestamp": 1586456896911,
      "identifier": {
        "doi": "10.1182/blood-2014-04-571323"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2012-09-453555"
  },
  "publisher": "American Society of Hematology",
  "title": "Lamarque M, Raynaud S, Itzykson R, et al. The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience. Blood. 2012;120(25):5084-5085."
}
